Zhengye Biotechnology Holding (ZYBT) Long-Term Deferred Tax (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Long-Term Deferred Tax data on file, last reported at $14663.2 in Q4 2025.

• Long-Term Deferred Tax for Q4 2025 came in at $14663.2, down 99.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $14663.2 (down 99.04% YoY), and the FY2025 annual result was $15000.0, down 99.0% from the prior year.
• Long-Term Deferred Tax declined to $14663.2 in Q4 2025 per ZYBT's latest filing, from $2.3 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $2.3 million in Q2 2025 and troughed at $14663.2 in Q4 2025.
• A 3-year average of $1.4 million and a median of $1.6 million in 2023 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2024 and 2025: Long-Term Deferred Tax retreated 7.53% in 2024, then sank 99.04% in 2025.
• A 3-year view of Long-Term Deferred Tax shows it stood at $1.7 million in 2023, then slipped by 7.53% to $1.5 million in 2024, then plunged by 99.04% to $14663.2 in 2025.
• Business Quant data shows ZYBT's Long-Term Deferred Tax at $14663.2 in Q4 2025, $2.3 million in Q2 2025, and $1.5 million in Q4 2024.